Clinical Trials in Atlanta

Showing 3421-3440 of 19,805 trials

Abatacept as GVHD Prophylaxis Phase 2

NCT01743131

This is a phase II multi-center, randomized, double blind, placebo-controlled trial. The investigators are doing this study to see if a new drug, abatacept, can be used together with a calcineurin inhibitor (cyclosporine or tacrolimus) and methotrexate to provide better protection against Acute Graft versus Host Disease (aGvHD) without causing more infections.

Graft vs Host DiseaseMalignancy

Boston Children's Hospital186 participantsStarted Feb 2013

Los Angeles, California, United States • Oakland, California, United States • Aurora, Colorado, United States +11 more locations

Active Not RecruitingPhase 3< 1 mile

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

NCT04540497

This study aims to evaluate the efficacy and safety of inebilizumab for the prevention of flare of Immunoglobulin G4-related disease (IgG4-RD).

IgG4 Related Disease

Amgen135 participantsStarted Dec 2020

Palo Alto, California, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +69 more locations

Abatacept as GVHD Prophylaxis Phase 2

A Study of Inebilizumab Efficacy and Safety in IgG4- Related Disease

Find Trials by Condition in Atlanta

Evaluation of BE1116 in Patients With Traumatic Injury and Acute Major Bleeding to Improve Survival ( TAP Study )

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

FastWire REvascularisation of Extremities, (For LOWer Limbs) - FREEFLOW

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle Prominence

PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

Treatment of Moderate to Severe Refractory Crohn's Disease

A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma

CapTemY90 for Grade 2/3 NET Liver Metastases

Evaluation of A Clinical Diagnostic Test for CRDS